White House says Trump opposes Senate's bipartisan Obamacare deal | | WASHINGTON (Reuters) - A bipartisan deal from two senators to stabilize Obamacare by restoring subsidies to health insurers suffered major setbacks on Wednesday with the White House saying President Donald Trump now opposes it and senior Republicans speaking out against it. |
| |
China biotech's 'coming out party' masks long road ahead | | LONDON/SHANGHAI (Reuters) - Investors are betting on China's potential to feed the global pharmaceutical pipeline, putting a multi-billion-dollar price tag on a handful of stocks, even as the country struggles to close a huge R&D gap with the West. |
| |
McDonald's South Korea office raided in burger probe: reports | | SEOUL (Reuters) - South Korean investigators raided the Seoul office of McDonald's Corp on Wednesday following a series of complaints that children fell ill after eating hamburger patties alleged to have been undercooked, Yonhap News Agency and other media said. |
| |
Cancer drug prices rising far faster than inflation | | (Reuters Health) - The prices of injectable cancer drugs - even older medicines around since the 1990s - are increasing at a rate far higher than inflation, researchers report in the Journal of Clinical Oncology. |
| |
Epidurals may not make labor last longer | | (Reuters Health) - Giving pregnant women spinal anesthesia known as an epidural to ease their pain during the late stages of labor and delivery may not prolong the process, a new experiment suggests. |
| |
Allergan ruling casts doubt on tribal patent strategy | | (Reuters) - A U.S. judge’s ruling on Monday invalidating Allergan Plc's patents on its blockbuster $1.5 billion dry-eye medicine, Restasis, has cast doubt on the company's novel strategy to enlist a Native American tribe to help shield those patents from challenge by generic drugmakers, legal experts said. |
| |
| | |